NVO - Novo Nordisk A/S

Your Recent Quotes: 0 | 0

Novo Nordisk A/S

TRADE NOW Related Information and Financials
Price Glossary Definition
45.10 -0.32
-0.70%
11/21/08 4:04
Open
46.79
Prev Close
45.42
Volume
415,084
52 Wk. Range
41.90- 73.73
Year-to-Date Performance Glossary Definition
DOWN -30.47%
Latest Dividend
Dividend
0.68
Yield
1.50
Ex-Date
03/13/2008
Price/Earnings Comparisons Glossary Definition
 
18.33
 
13.50
 
13.40
NVO
Sect. Av.
S&P 500
Market Cap
23,745,736,300
Outstanding Shares
539,473,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy NVO Rating Report
Target Price (1Yr)
High
66.80
Revenue
9.25B

Annual Dividend
Rate
0.88
Yield
2.00
Growth
12 Month
3 Year
CAGR
Revenue
19.40
0.54
0.15
Net Income
46.10
0.81
0.22
EPS
48.00
0.93
0.24

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
-22.50
-28.33
66.91
Earnings Per Share($)

12/2005
 
 
 
1.42
12/2006
 
 
 
1.78
12/2007
 
 
 
2.64

Earnings
EBITDA
2.28B
Revenue
8.19B
Outside Analyst Rating History

11/23/08
1
Buy
11/23/08
3
Hold
11/23/08
2
Sell

Jim Cramer Portfolio
Find out now if NVO is in Jim's personal portfolio at Action Alerts PLUS.

Price & Volume

Compare This Stock
Latest Headlines
The biotech's shares rise on news of an increased bet by investor Carl Icahn and an uptick in its diabetes drug's prescription data.

5:40PM 11/17/08

But the diabetes-drug maker still faces hurdles in winning back investor confidence.

3:19PM 11/17/08

Shares of the drugmakers tumble on news their application for long-acting version of the diabetes drug Byetta don't meet FDA requirements.

12:48PM 11/04/08

Shares of the drugmakers tumble on news their application for long-acting version of the diabetes drug don't meet FDA requirements.

10:42AM 11/04/08

Cramer likes the company's future prospects no matter who wins in November.

7:19PM 09/11/08

The trading panel looks at the housing sector in the wake of the takeover of Fannie and Freddie.

7:26PM 09/08/08

Cramer says the Fed needs to step up and stop the deflation.

7:35PM 09/05/08

Don't rush into buying the drugmaker just because it may be unfarily beaten down by safety concerns for diabetes drug Byetta.

1:20PM 08/22/08

The trading panel notes that the company surprised the shorts and beat earnings.

6:48PM 06/26/08

The team says Kroger's new numbers are 'surprisingly lovely.' Rising food prices are not hurting its margins.

7:03PM 06/24/08

Understanding the Market

Our Experts' Take at RealMoney
However, option traders boost January calls.

4:37PM 11/21/08

This market is producing a few stocks that could represent exceptional opportunities.

3:03PM 11/21/08

More Experts' Takes


Premium Stock Ideas
Is Cramer trading NVO in his Action Alerts Plus Portfolio?

Premium Services